zip >>> 02210
sector >>> Healthcare
fullTimeEmployees >>> 3000
longBusinessSummary >>> Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial; VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial; and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; Molecular Templates, Inc.; and Affinia Therapeutics. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
city >>> Boston
phone >>> 617 341 6100
state >>> MA
country >>> United States
companyOfficers >>> []
website >>> http://www.vrtx.com
maxAge >>> 1
address1 >>> 50 Northern Avenue
industry >>> Biotechnology
previousClose >>> 263.13
regularMarketOpen >>> 264.1
twoHundredDayAverage >>> 267.36633
trailingAnnualDividendYield >>> None
payoutRatio >>> 0
volume24Hr >>> None
regularMarketDayHigh >>> 268.91
navPrice >>> None
averageDailyVolume10Day >>> 1363314
totalAssets >>> None
regularMarketPreviousClose >>> 263.13
fiftyDayAverage >>> 268.16528
trailingAnnualDividendRate >>> None
open >>> 264.1
toCurrency >>> None
averageVolume10days >>> 1363314
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> None
exDividendDate >>> None
beta >>> 0.846153
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 260.52
priceHint >>> 2
currency >>> USD
trailingPE >>> 33.84829
regularMarketVolume >>> 1345847
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 69852037120
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 1311949
priceToSalesTrailing12Months >>> 12.929134
dayLow >>> 260.52
ask >>> 267
ytdReturn >>> None
askSize >>> 800
volume >>> 1345847
fiftyTwoWeekHigh >>> 306.08
forwardPE >>> 23.628193
fromCurrency >>> None
fiveYearAvgDividendYield >>> None
fiftyTwoWeekLow >>> 165.23
bid >>> 263
tradeable >>> False
dividendYield >>> None
bidSize >>> 1200
dayHigh >>> 268.91
exchange >>> NMS
shortName >>> Vertex Pharmaceuticals Incorpor
longName >>> Vertex Pharmaceuticals Incorporated
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EDT
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -14400000
quoteType >>> EQUITY
symbol >>> VRTX
messageBoardId >>> finmb_36235
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 12.017
beta3Year >>> None
profitMargins >>> 0.38514
enterpriseToEbitda >>> 29.378
52WeekChange >>> 0.58292997
morningStarRiskRating >>> None
forwardEps >>> 11.35
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 260467008
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 28.906
sharesShort >>> 3348466
sharesPercentSharesOut >>> 0.0128999995
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.97827005
netIncomeToCommon >>> 2080775040
trailingEps >>> 7.923
lastDividendValue >>> None
SandP52WeekChange >>> 0.108078
priceToBook >>> 9.277658
heldPercentInsiders >>> 0.0013600001
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1593475200
shortRatio >>> 2.77
sharesShortPreviousMonthDate >>> 1596153600
floatShares >>> 260087052
enterpriseValue >>> 64923426816
threeYearAverageReturn >>> None
lastSplitDate >>> 967075200
lastSplitFactor >>> 2:1
legalType >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> 2.131
dateShortInterest >>> 1598832000
pegRatio >>> 1.09
lastCapGain >>> None
shortPercentOfFloat >>> 0.0128999995
sharesShortPriorMonth >>> 3363776
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 264.1
logo_url >>> https://logo.clearbit.com/vrtx.com
